CB2 receptor — Drug Target
All drugs that target CB2 receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- ZYN002 - transdermal gel · Zynerba Pharmaceuticals, Inc. · cannabinoid · Epilepsy
ZYN002, a transdermal gel formulation of cannabidiol, is thought to exert its therapeutic effects through its action on the endocannabinoid system.